Asset Management One Co. Ltd. Buys 5,072 Shares of STERIS plc $STE

Asset Management One Co. Ltd. lifted its position in STERIS plc (NYSE:STE) by 5.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,487 shares of the medical equipment provider’s stock after acquiring an additional 5,072 shares during the period. Asset Management One Co. Ltd. owned approximately 0.10% of STERIS worth $24,366,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Fifth Third Wealth Advisors LLC acquired a new position in STERIS in the third quarter valued at about $615,000. TruNorth Capital Management LLC acquired a new position in shares of STERIS in the 3rd quarter valued at approximately $37,000. Simon Quick Advisors LLC increased its stake in STERIS by 20.6% during the 3rd quarter. Simon Quick Advisors LLC now owns 3,513 shares of the medical equipment provider’s stock worth $869,000 after purchasing an additional 601 shares in the last quarter. Taylor Frigon Capital Management LLC raised its holdings in STERIS by 2.1% during the 3rd quarter. Taylor Frigon Capital Management LLC now owns 6,316 shares of the medical equipment provider’s stock worth $1,563,000 after buying an additional 129 shares during the period. Finally, Suncoast Equity Management raised its holdings in STERIS by 3.4% during the 3rd quarter. Suncoast Equity Management now owns 4,512 shares of the medical equipment provider’s stock worth $1,117,000 after buying an additional 150 shares during the period. Institutional investors own 94.69% of the company’s stock.

Insider Activity

In related news, VP Renato Tamaro sold 5,036 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the transaction, the vice president directly owned 5,695 shares of the company’s stock, valued at approximately $1,466,747.25. This represents a 46.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Julia Madsen sold 5,008 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $262.00, for a total value of $1,312,096.00. Following the completion of the transaction, the vice president owned 10,710 shares of the company’s stock, valued at approximately $2,806,020. This represents a 31.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 25,044 shares of company stock worth $6,586,218 in the last quarter. Corporate insiders own 1.07% of the company’s stock.

STERIS Price Performance

Shares of STE opened at $256.63 on Tuesday. The company has a quick ratio of 1.63, a current ratio of 2.37 and a debt-to-equity ratio of 0.27. STERIS plc has a twelve month low of $203.35 and a twelve month high of $268.60. The stock has a market capitalization of $25.19 billion, a P/E ratio of 36.87 and a beta of 1.03. The company has a 50 day moving average of $255.78 and a 200-day moving average of $245.26.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. STERIS had a net margin of 12.07% and a return on equity of 14.43%. During the same quarter in the previous year, the firm posted $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, equities research analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Tuesday, November 18th were paid a dividend of $0.63 per share. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date was Tuesday, November 18th. STERIS’s dividend payout ratio is currently 36.21%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research report on Tuesday, October 14th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, STERIS has an average rating of “Moderate Buy” and an average target price of $273.50.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.